Treatment of intrabony periodontal defects in controlled diabetic patients with an enamel matrix derivative: a split-mouth randomized clinical trial.

Renata CimõesLeógenes M SantiagoArnaldo de França Caldas JúniorBruna de Carvalho Farias VajgelJeniffer PerussoloNikolaos Donos

Published in: Clinical oral investigations (2021)

This study showed a better PPD reduction and CAL gain when an EMD was applied in addition to SPPF. Therefore, EMD may be used to enhance clinical outcomes in periodontal ID of controlled T2DM patients.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
type diabetes
prognostic factors
clinical trial
metabolic syndrome
adipose tissue
weight loss
wound healing
smoking cessation
patient reported